Engine explained, runway named: management decomposes current strength into specific still-working causes and points to
The model's full reasoning — Q3 2016 call → NOWe need answer YES/NO based on transcript. Need assess if management explains current strength by naming specific causes and indicates same causes have specific identified room left. Transcript: Q3 2016. Management discusses progress. Need find current strength decomposed into named causes. Examples: margetuximab Phase 3 SOPHIA enrolling, 90% sites activated. But is that "strength" in business? They mention progress. Enoblituzumab combination with pembrolizumab advanced into dose expansion cohorts. MGD010 regained rights, finished last subject. MGA012 IND cleared. They have nine programs. But need current strength with specific drivers and room left. Question asks: "On this call, does management EXPLAIN THE CURRENT STRENGTH OF THE BUSINESS BY NAMING ITS SPECIFIC CAUSES — identifying the particular driver or drivers (one is enough) behind results, orders, volumes, customers, or activity that are demonstrably good right now — AND does management indicate that those SAME causes are still in force with SPECIFIC, IDENTIFIED ROOM LEFT that they have not yet consumed?" Need answer based on transcript. Management doesn't really discuss financial results as strength? They report net loss, expenses. They mention progress in pipeline. Could be "current strength" in clinical development. Need see if they name specific causes and room left. For example, margetuximab: "continues to be further advanced clinical program and is accurately enrolling patients and initiating new trial types for the pivotal Phase 3 SOPHIA study... As of September 30, approximately 90% of the anticipated trial sites have been activated in both the U.S. and Europe." That is specific: sites activated, enrollment. Room left? They say "we continue to enroll patients and activate two clinical sites" and "we plan to provide more precision about estimates with regard to completion of enrollment and readout of data." They don't explicitly say same cause has specific unconsumed room? They say 90% sites activated, so 10% not activated. But is that "room"? Also enrollment ongoing, but no specific number. They mention "we expect to provide little more detail next month." Not enough. Enoblituzumab: "combination study with pembrolizumab has advanced into dose expansion cohorts, while the enoblituzumab study is completing the last dose-escalation cohort." That is progress.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| ECPG | Encore Capital Group, Inc. | Q1 2024 | 2024-05-08 | B |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| GRBK | Green Brick Partners, Inc. | Q3 2023 | 2023-11-01 | B |
| FSBC | Five Star Bancorp | Q3 2023 | 2023-10-31 | B |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| NMR | Nomura Holdings, Inc. | Q1 2024 | 2023-08-02 | D |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| SLF | Sun Life Financial Inc. | Q1 2023 | 2023-05-12 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| WGO | Winnebago Industries, Inc. | Q1 2023 | 2022-12-16 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| CIVB | Civista Bancshares, Inc. | Q2 2022 | 2022-07-31 | B |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| CME | CME Group Inc. | Q2 2022 | 2022-07-27 | B |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| FFWM | First Foundation Inc. | Q3 2021 | 2021-10-26 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| DGX | Quest Diagnostics Incorporated | Q2 2021 | 2021-07-22 | B+ |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| ALKS | Alkermes plc | Q3 2018 | 2018-10-23 | C |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| CLMT | Calumet Specialty Products Partners, L.P | Q1 2018 | 2018-05-16 | C+ |
| LAUR | Laureate Education, Inc. | Q1 2018 | 2018-05-13 | B+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| PCRX | Pacira BioSciences, Inc. | Q4 2017 | 2018-02-28 | C |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| SBFG | SB Financial Group, Inc. | Q3 2017 | 2017-10-20 | A |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| TPB | Turning Point Brands, Inc. | Q1 2017 | 2017-05-11 | B |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ICFI | ICF International, Inc. | Q1 2017 | 2017-05-06 | B+ |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| SXT | Sensient Technologies Corporation | Q4 2016 | 2017-02-10 | A |
| EVBN | Evans Bancorp, Inc. | Q4 2016 | 2017-02-06 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| SOHO | Sotherly Hotels Inc. | Q3 2016 | 2016-11-08 | D |
| MAT | Mattel, Inc. | Q3 2016 | 2016-10-19 | C |
| CGNX | Cognex Corporation | Q2 2016 | 2016-08-01 | A |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| SAN | Banco Santander, S.A. | Q4 2015 | 2016-01-27 | B |
| JJSF | J&J Snack Foods Corp. | Q1 2016 | 2016-01-26 | C |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
DAL · Q2 2023 → YESThe question is about whether management explains the current strength by naming specific causes and indicates those same causes have unconsumed room left. YES Management explains current strength through specific named drivers: premium revenue growth of 25% (with Delta Premium Select now on over 80% of wide-body fleet and "customer response terrific"), loyalty revenue up 20% (Amex co-brand portfolio), international passenger revenue +61% (led by TransAtlantic and Latin America), domestic +8%, core hub rebuild advancing (Atlanta focus), and coastal facility investments progressively improving margins. These are concrete, product- and position-specific causes tied to actual results. The same drivers retain unconsumed room: premium and loyalty are on track to exceed $6.
ECPG · Q1 2024 → YESThe question is about whether management explains the current strength of the business by naming specific causes and indicates those same causes have unconsumed room left. YES The transcript shows current strength from specific drivers: U.S. portfolio supply growth (credit card lending + 10-year-high charge-offs) creating attractive pricing/returns, plus record $237M U.S. deployments and 500 new account managers now generating scale efficiencies. These same drivers remain active with unconsumed 2024 runway—continued record supply, new staff gaining experience, and recent purchases still flowing into collections over the next few years—while management reaffirms 2024 guidance for purchasing above 2023 levels and collections growth.
CLMT · Q1 2018 → YESThe question is: Does management explain the current strength of the business by naming its specific causes AND indicate that those same causes are still in force with specific, identified room left t...YES Management decomposes current strength into concrete drivers: branded-products division growth (high-margin mix), self-help initiatives ($8.3 million incremental EBITDA from new-product introductions, margin enhancements, and improved raw-material sourcing), and fuels-segment optimization via record premium gasoline volumes at Shreveport plus processing of discounted WCS ( 23,000 bpd) and Midland WTI (6,500 bpd) crudes, all yielding higher gross profit per barrel despite turnarounds and rising crude prices.